STAT+: 3 reasons the drug industry should be worried about Biden’s HHS pick, Xavier Becerra
WASHINGTON — For a pharmaceutical industry that has spent two years sparring with health secretary…
Category: Biotech
Opinion: The mental health dilemma: If technology is the problem, can it also be the solution?
The must-see Netflix documentary, “The Social Dilemma,” released early this year, draws attention to the…
Opinion: As a physician and a patient, I’ve seen the damage caused by the stigma of addiction. It must end
Although the disease of addiction is now obscured by the dark cloud of the Covid-19…
Biden’s health picks signal a bottom-up approach to the Covid-19 pandemic
President-elect Biden’s pandemic-response strategy took clearer shape this week with the rollout of several surprising…
STAT+: Months of limbo at OpenBiome put fecal matter transplants on hold across the country
New regulations put in place because of Covid-19 have left one of the largest U.S….
Biden’s CDC pick, a savvy communicator, will take over at a time when agency’s voice has been muted
When Rochelle Walensky, head of infectious diseases at Massachusetts General Hospital, walks into the Centers…
STAT+: FDA finds fault with a Bristol plant, but it may not upset key approval of a cancer drug
The Food and Drug Administration found problems during a recent inspection of a Bristol Myers…
STAT+: Divergent results from Agios, Forma trials for their sickle cell disease drugs
Two drug makers — Forma Therapeutics and Agios Pharmaceuticals — are each developing their own…
Leading Covid-19 vaccine makers Pfizer and Moderna decline invitations to White House ‘Vaccine Summit’
Both Pfizer and Moderna, the two major drug manufacturers likely to receive emergency authorizations for…
STAT+: With new data and a storied history, Eli Lilly’s blood cancer pill is looking stronger
Three years ago, the biotech firm Loxo Oncology purchased a promising blood cancer pill for…
.jpg)
STAT+: Pharmalittle: Biden taps HHS and CDC heads; U.S. taxpayers may get a payback on Gilead’s remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: A new rule that protects VA clinicians who practice across state lines should kick off a movement
Amid the pandemonium of a turbulent election and a resurgent virus, the Department of Veterans…
Opinion: Covid-19 vaccine safety and the public trust: lessons from Paul Meier and polio
Early results of the Covid-19 vaccine trials sponsored by Pfizer, Moderna, and AstraZeneca are welcome…
STAT+: A payoff for U.S. taxpayers? CDC may have claims on remdesivir patents held by Gilead
Six years ago, a team of scientists at the Centers for Disease Control and Prevention…
On the ground, the pledge to vaccinate 20 million against Covid-19 in December seems unrealistic
Hospitals across the United States are preparing for a Covid-19 vaccine distribution timeline that’s well…
STAT+: Constellation’s blood cancer drug shows greater benefit, easing concerns about its future
More patients and an improved response rate might once again shift the sentiment on Constellation…
STAT+: J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
More than three-quarters of the multiple myeloma patients treated with an experimental CAR-T therapy from…
STAT+: Genetically targeted drug from Kura Oncology induces remissions in adult leukemia patients
Kura Oncology presented early clinical trial results Saturday showing for the first time that its…
Preliminary but ‘nothing short of great.’ New data on CRISPR treatment for blood diseases suggest cure is possible
Ten patients treated with a CRISPR-based gene-editing therapy for the inherited blood disorders sickle cell…
Opinion: Women’s perspectives and voices need more inclusion in Covid-19 media coverage
As media coverage of Covid-19 continues 24/7, it routinely ignores an important dimension of the…
STAT+: FTC says the number of pay-to-delay cases remains low, but vows to keep watch
Although more drug makers are settling patent infringement lawsuits, the U.S. Federal Trade Commission found…
How key decisions slowed FDA’s review of Covid-19 vaccine — but also gave it important data
In September, as Pfizer and partner BioNTech were quickly advancing a study of their Covid-19…
STAT+: BIO to file lawsuit today to block Trump international drug pricing policy
WASHINGTON — The Biotechnology Innovation Organization will file a lawsuit today to block implementation of…
STAT+: A longtime health care investor on the wild ride of 2020 and what to expect in 2021
It’s time to talk about biotech and 2021. What will the year ahead look like…
STAT+: Pharmalittle: Cyberattacks and criminal gangs target Covid-19 vaccines; whistleblower raps FDA oversight
And so, another working week will soon draw to a close. Not a moment too…
CommonHealth, the Android answer to Apple health records, expands to 230 health systems
A cohort of researchers and developers announced Friday that the Android app CommonHealth — which…
Opinion: Drug companies’ payments and gifts affect physicians’ prescribing. It’s time to turn off the spigot
Each year, about half of all U.S. doctors accept money or gifts from drug and…
Opinion: Replace the ‘cold steel’ of hospital-bed shackles with the warmth of compassion
“Why do they have that cold steel on my son’s ankle?” The father of Jacob…
.jpg)
‘Already in short supply’: How climate change could chip away at sleep health
In October 2015, Nick Obradovich was living in San Diego when an intense heatwave smothered…
AstraZeneca’s confusing vaccine data, biotech in 2021, and a guide to the ASH conference
Can too much Covid-19 vaccine be a bad thing? Is biotech in a bubble? And…
CDC advisory panel’s lone dissenter on why long-term care residents shouldn’t receive Covid-19 vaccine first
When a Centers for Disease Control and Prevention advisory committee voted Tuesday to recommend residents…
STAT+: With growing usage and few generics, Medicare spending on inhalers is climbing
Over a recent seven-year period, Medicare Part D spending on inhalers used to control respiratory…
Public health experts are pressuring Biden to include health expertise in his cabinet
Prominent public health experts are pressuring President-elect Biden and his team to include a doctor…
STAT+: Pharmalittle: FDA’s Hahn defends Covid-19 vaccine vetting; U.K. denies cutting corners to approve Pfizer shot
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Steered by a former Uber Health exec, a new startup aims to bridge in-home care and telemedicine
Telemedicine has become a lifeline during the Covid-19 pandemic, but it is not enough help…
Opinion: Extending health care to all ethically and practically: lessons from Covid-19
The long-standing debate over whether health care is a right or a privilege seems particularly…
Opinion: A better way to roll out Covid-19 vaccines: Vaccinate everyone in several hot zones
Dear CEOs of Pfizer, Moderna, and AstraZeneca, Thank you for rapidly mobilizing your scientific resources…
Opinion: Make science bipartisan again
The Biden-Harris administration faces daunting challenges. Chief among them is tackling the Covid-19 pandemic and…
‘There absolutely will be a black market’: How the rich and privileged can skip the line for Covid-19 vaccines
Bill Lang didn’t get much of a break over Thanksgiving. Almost every day last week,…
Elevated stress hormone levels could reawaken dormant cancer cells, study finds
The recurrence of cancer months or even years after successful treatment is an all too…
STAT+: Covid-19 vaccines will arrive before the data sharing technology that could help track them
Scientists have produced Covid-19 vaccines in record time. But the digital connectivity needed to closely…
STAT+: Genetic reprogramming rejuvenates nerve cells and restores vision in mice
For years now, biologists have been practicing a kind of time travel. You can take…
Opinion: Misguided federal regulations are likely to cause more pain in people already living with it
Hidden in the shadows of the Covid-19 pandemic is the U.S.’s drug epidemic, which is…
STAT+: Pharmalittle: U.K. approves Pfizer Covid-19 vaccine; Trump pressures FDA to approve Covid-19 shots
Rise and shine, everyone, another busy day is on the way. In fact, the middle…
U.K. approves Pfizer’s Covid-19 vaccine, putting pressure on FDA
The United Kingdom on Wednesday became the first country to approve a Covid-19 vaccine developed…
Opinion: Better collection, reporting of race and ethnicity data are essential for fighting Covid-19
This year has challenged Americans to confront their understanding of society and to start rewriting…
Opinion: Advice for the next CMS administrator’s first 100 days
This week four years ago, I was working for the Centers for Medicare and Medicaid…
The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them
It appears science may have found the Covid-19 pandemic’s off-ramp. Two vaccines developed with stunning…
Health workers, long-term care facilities should get Covid-19 vaccine first, CDC advisory panel says
A committee that advises the Centers for Disease Prevention and Control voted overwhelmingly on Tuesday…
STAT+: Ovid’s treatment for a rare, untreatable disease fails in a key trial
Ovid Therapeutics’ experimental drug for a devastating rare disease proved no better than placebo in…